Cart

0

Cali-Greenhouse Blog

France chooses companies to supply free medical cannabis for trial program

Buying Weed Online Discretely
France medical cannabis, France chooses companies to supply free medical cannabis for trial program

Buying Weed Online Discretely.The French

Agency for the Safety of Medicines and Health

Products (ANSM) selected the companies that will

supply France’s medical cannabis pilot program 

that’s intend to provide free products to patients

enrol in the trial.

Cannabis companies from Australia, Canada, Israel

and the United Kingdom – in partnership with French

pharmaceutical distributors – will provide the products

for up to 3,000 patients and will not receive any money 

for supplying the medical cannabis.

French authorities selected main suppliers, as well as

substitute suppliers to cover any shortfalls.

Buying Weed Online Discretely

The list of suppliers includes:

  • Australia-based Althea (one lot as a substitute)
  • and Little Green Pharma (two lots as a main
  • supplier and one lot as a substitute).
  • Canada-based Aurora Cannabis (three lots as a
  • main supplier) and Tilray (two lots as a main
  • supplier and two lots as a substitute).
  • Israel-based Panaxia (two lots as a main supplier
  • and two lots as a substitute).
  • U.K.-based Emmac Life Sciences (two lots as
  • a substitute).

Applicants were judge on products, manufacturing

and supply criteria.

Neither the government nor patients will have to pay

for the medical marijuana, which will be supply by

the participating companies at their own cost.

The participating companies have no guarantee they

will remain suppliers in the event France broadens

access to medical cannabis after the experiment.

However, “with hundreds of patients already treat

(at the end of the experiment) and doctors use to

prescribing their products, this is probably a marketing

advantage,” Nicolas Authier, a university professor and

chair of the ANSM scientific committee on medical

cannabis, said last October.

Cannabis products will be use only as a

last resort

and must meet pharmaceutical-quality standards.

Only patients with certain qualifying conditions 

will be permit to participate in the trial.

“Distance learning for health professionals should

start at the end of February and the first prescriptions

before March 31,” Authier told MJBizDaily.

Here’s the complete list of suppliers and their partners

for distribution:

THC dominant

Lot 1.1: Flower with more than 8% THC and less

than 1% CBD.

  • Main supplier: Aurora in partnership with
  • Ethypharm.
  • Substitute: Tilray in partnership with Medipha
  • Sante.

Lot 1.2: Sublingual oil with more than 5

milligrams of THC

per milliliter and less than 1 milligram of

CBD per milliliter.

  • Main supplier: Tilray in partnership with
  • Medipha Sante.
  • Substitute: Panaxia in partnership Neuraxpharm
  • France.

Lot 1.3: Oral oils with more than 5 milligrams of THC

per milliliter and less than 1 milligram of CBD per

milliliter.

  • Main supplier: Panaxia in partnership with
  • Neuraxpharm France.
  • Substitute: Emmac Life Sciences in partnership
  • with Boiron.

THC and CBD balance:

Lot 2.1: Flower with more than 5% THC and

5% CBD.

  • Main supplier: Aurora in partnership with
  • Lot 2.1: Flower with more than 5% THC and
  • Ethypharm.
  • Lot 2.1: Flower with more than 5% THC and
  • Substitute: Tilray in partnership with Medipha
  • Sante.

Lot 2.2: Sublingual oil with more than 5 milligrams of

THC and 5 milligrams of CBD per milliliter.

Lot 2.1: Flower with more than 5% THC and

  • Main supplier: Tilray in partnership with
  • Lot 2.1: Flower with more than 5% THC and
  • Medipha Sante.
  • Substitute: Little Green Pharma in partnership
  • Lot 2.1: Flower with more than 5% THC and
  • with Intsel Chimos.

Lot 2.3: Oral oils with more than 5 milligrams of THC

and 5 milligrams of CBD per milliliter.

Lot 2.1: Flower with more than 5% THC and

  • Main supplier: Panaxia in partnership with
  • Lot 2.1: Flower with more than 5% THC and
  • Neuraxpharm.
  • Substitute: Emmac Life Sciences in partnership
  • with Boiron.

CBD dominant:

Lot 3.2: Sublingual oil with less than 1 milligram of

THC per milliliter and more than 5 milligrams of CBD

per milliliter.

  • Main supplier: Little Green Pharma in partnership
  • with Intsel Chimos.
  • Substitute: Althea in partnership Laboratoires
  • Bouchara Recordati.

Lot 3.4: Flower with less than 5% THC and more

than 5% CBD.

Main supplier: Aurora in partnership with Ethypharm.

No substitute.

Lot 3.5: Sublingual oil with less than 5 milligram of THC per

milliliter and more than 5 milligram of CBD per milliliter.

  • Main supplier: Little Green Pharma in partnership
  • Intsel Chimos.
  • Substitute: Panaxia in partnership with
  • Neuraxpharm France.

The CBD-dominant category originally had six lots

in the application process, but suppliers were select

only for the three lots mention above.

Buy edibles online, Buy cannabis oil, Buy CBD distilate online , buy concentrates online, Buy moon rocks, Buy vapes, ,buy wax online

X